| Application no. and date | 14707887.7 (espacenet) (Federated) (European Patent Register), 20140212 | | Patent/reg. no. and date | DK/EP 2956464, 20180328 | | Publication date | 20151223 | | Priority no. and date | US 201361764679 P, 20130214 | | EP pub. no. and date |
EP 2956464 20151223 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157119 | | Inventor | BARNES, David, Weninger, 100 Technology Square
Cambridge, Massachusetts 02139, US,
COHEN, Scott, Louis, 100 Technology Square
Cambridge, Massachusetts 02139, US,
RIGEL, Dean, Franklin, One Health Plaza
East Hanover, New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/662 (2006.01) , A61K 31/665 (2006.01) , A61K 31/675 (2006.01) , A61K 45/06 (2006.01) , C07F 9/38 (2006.01) , C07F 9/572 (2006.01) , C07F 9/59 (2006.01) , C07F 9/655 (2006.01) | | Title | Substituerede bisphenyl-butan-phosphonsyrederivater som NEP (neutral endopeptidase)-inhibitorer | | Int. application no. | US2014015980 | | Int. publication no. | WO2014126979 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
